These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15152700)

  • 1. Why don't Americans use cost-effectiveness analysis?
    Neumann PJ
    Am J Manag Care; 2004 May; 10(5):308-12. PubMed ID: 15152700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategic plan for integrating cost-effectiveness analysis into the US healthcare system.
    Neumann PJ; Palmer JA; Daniels N; Quigley K; Gold MR; Chao S;
    Am J Manag Care; 2008 Apr; 14(4):185-8. PubMed ID: 18402510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency-based healthcare. General concepts on economic evaluation of healthcare interventions].
    Catalá-López F
    Enferm Clin; 2009; 19(1):35-42. PubMed ID: 19233020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualizing the infrastructure of US healthcare using Internet GIS: a community health informatics approach for reducing health disparities.
    Fulcher CL; Kaukinen CE
    Stud Health Technol Inform; 2004; 107(Pt 2):1197-201. PubMed ID: 15361002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AHRQ series commentary 3: the United States addresses comparative effectiveness but not cost-effectiveness through the effective health-care program.
    Freemantle N; Drummond MF
    J Clin Epidemiol; 2010 May; 63(5):479-80. PubMed ID: 20346862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the time come for cost-effectiveness analysis in US health care?
    Bryan S; Sofaer S; Siegelberg T; Gold M
    Health Econ Policy Law; 2009 Oct; 4(Pt 4):425-43. PubMed ID: 19203399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding cost-effectiveness.
    Zilberberg MD; Shorr AF
    Clin Microbiol Infect; 2010 Dec; 16(12):1707-12. PubMed ID: 20673258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of early intervention services.
    McCrone P; Knapp M
    Br J Psychiatry Suppl; 2007 Dec; 51():s19-22. PubMed ID: 18055933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed cost effectiveness method for use in policy formulation in human service organizations.
    Holosko MJ; Dobrowolsky J; Feit MD
    J Health Soc Policy; 1990; 1(3):55-71. PubMed ID: 10113664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic analysis in healthcare decisions.
    Tunis SR
    Am J Manag Care; 2004 May; 10(5):301-4. PubMed ID: 15152698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence-based health care requires knowledge of cost-effectiveness].
    Carlsson P
    Lakartidningen; 2002 Jul; 99(30-31):3122-6. PubMed ID: 12198932
    [No Abstract]   [Full Text] [Related]  

  • 15. Using cost-effectiveness analysis in policy formulation in human service organizations.
    Holosko MJ; Dobrowolsky J; Feit MD
    J Health Soc Policy; 1989; 1(1):43-60. PubMed ID: 10313498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and evidence evaluation as criteria for coverage policy.
    Garber AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-284-96. PubMed ID: 15451997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value for money in health and medical care services.
    Bloom BS
    Am J Manag Care; 2002 Mar; 8(3):266-8. PubMed ID: 11915976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.